Use of granulocyte colony-stimulating factor in patients with chemotherapy-induced neutropaenia

Use of granulocyte colony-stimulating factor in patients with chemotherapy-induced neutropaenia

Background: Febrile neutropaenia (FN) and resultant infections are the major cause of treatment-related morbidity and mortality in patients receiving chemotherapy. Clinical practice guidelines recommend the use of granulocyte colony-stimulating factors (G-CSF) to reduce the risk of FN and ensuing co...

Full description

Bibliographic Details
Main Authors: Lucky L. Shokane, Selente Bezuidenhout, Maryke Lundie
Format: Article
Language:Afrikaans
Published: AOSIS 2023-03-01
Series:Health SA Gesondheid: Journal of Interdisciplinary Health Sciences
Subjects:
chemotherapy
febrile neutropaenia
g-csf
guidelines compliance
dosage
Online Access:https://hsag.co.za/index.php/hsag/article/view/2221

Internet

https://hsag.co.za/index.php/hsag/article/view/2221

Similar Items